Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

Related Articles by Review for PubMed (Select 9293544)

1.

Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.

Prados MD, Wara W, Edwards MS, Ater J, Rabbit J, Lamborn K, Davis R, Levin VA.

Pediatr Neurosurg. 1996 Oct;25(4):174-81.

PMID:
9293544
2.

[Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].

Kortmann RD, Kühl J, Timmermann B, Calaminus G, Dieckmann K, Wurm R, Sörensen N, Urban C, Göbel U, Bamberg M.

Strahlenther Onkol. 2001 Sep;177(9):447-61. Review. German.

PMID:
11591018
3.

Medulloblastoma: clinical and biologic aspects.

Packer RJ, Cogen P, Vezina G, Rorke LB.

Neuro Oncol. 1999 Jul;1(3):232-50. Review.

4.

Adult medulloblastoma: multiagent chemotherapy.

Greenberg HS, Chamberlain MC, Glantz MJ, Wang S.

Neuro Oncol. 2001 Jan;3(1):29-34. Review.

5.

Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.

Saran FH, Driever PH, Thilmann C, Mose S, Wilson P, Sharpe G, Adamietz IA, Böttcher HD.

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):959-67. Review.

PMID:
9869216
6.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

7.

The therapy of infantile malignant brain tumors: current status?

Kalifa C, Grill J.

J Neurooncol. 2005 Dec;75(3):279-85. Review.

PMID:
16195802
9.

Chemotherapy for medulloblastomas and primitive neuroectodermal tumors.

Cohen BH, Packer RJ.

J Neurooncol. 1996 Jul;29(1):55-68. Review.

PMID:
8817416
10.

Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor.

Paulino AC, Cha DT, Barker JL Jr, Lo S, Manera RB.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1171-6. Review.

PMID:
15001261
11.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
12.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
13.

Medulloblastomas and central nervous system primitive neuroectodermal tumors.

McLean TW.

Curr Treat Options Oncol. 2003 Dec;4(6):499-508. Review.

PMID:
14585230
14.

Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study.

Kovnar EH, Kellie SJ, Horowitz ME, Sanford RA, Langston JW, Mulhern RK, Jenkins JJ, Douglass EC, Etcubanas EE, Fairclough DL, et al.

J Clin Oncol. 1990 Feb;8(2):330-6. Review.

PMID:
2153766
15.
16.

Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.

Gajjar A, Pizer B.

Pediatr Blood Cancer. 2010 Apr;54(4):649-51. doi: 10.1002/pbc.22378. Review.

PMID:
20146223
17.

Combined modality therapy for intracranial tumors.

Bloom HJ.

Cancer. 1975 Jan;35(1):111-20. Review.

PMID:
162849
18.

Rational approaches to the chemotherapy of medulloblastoma.

Friedman HS, Schold SC Jr.

Neurol Clin. 1985 Nov;3(4):843-53. Review.

PMID:
3908899
19.

Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma.

Packer RJ, Sutton LN, D'Angio G, Evans AE, Schut L.

Pediatr Neurosci. 1985-1986;12(4-5):272-82. Review.

PMID:
3039477
20.

Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects.

Schild SE, Scheithauer BW, Schomberg PJ, Hook CC, Kelly PJ, Frick L, Robinow JS, Buskirk SJ.

Cancer. 1993 Aug 1;72(3):870-80. Review.

PMID:
8334641
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk